1. Home
  2. STRO vs TTSH Comparison

STRO vs TTSH Comparison

Compare STRO & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • TTSH
  • Stock Information
  • Founded
  • STRO 2003
  • TTSH 1985
  • Country
  • STRO United States
  • TTSH United States
  • Employees
  • STRO N/A
  • TTSH N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • TTSH Blank Checks
  • Sector
  • STRO Health Care
  • TTSH Finance
  • Exchange
  • STRO Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • STRO 77.7M
  • TTSH 275.5M
  • IPO Year
  • STRO 2018
  • TTSH N/A
  • Fundamental
  • Price
  • STRO $0.75
  • TTSH $6.36
  • Analyst Decision
  • STRO Hold
  • TTSH
  • Analyst Count
  • STRO 7
  • TTSH 0
  • Target Price
  • STRO $3.97
  • TTSH N/A
  • AVG Volume (30 Days)
  • STRO 1.4M
  • TTSH 70.2K
  • Earning Date
  • STRO 08-12-2025
  • TTSH 08-07-2025
  • Dividend Yield
  • STRO N/A
  • TTSH N/A
  • EPS Growth
  • STRO N/A
  • TTSH N/A
  • EPS
  • STRO N/A
  • TTSH 0.01
  • Revenue
  • STRO $66,434,000.00
  • TTSH $343,352,000.00
  • Revenue This Year
  • STRO N/A
  • TTSH N/A
  • Revenue Next Year
  • STRO N/A
  • TTSH N/A
  • P/E Ratio
  • STRO N/A
  • TTSH $378.59
  • Revenue Growth
  • STRO N/A
  • TTSH N/A
  • 52 Week Low
  • STRO $0.52
  • TTSH $4.62
  • 52 Week High
  • STRO $5.17
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • STRO 38.33
  • TTSH 52.73
  • Support Level
  • STRO $0.76
  • TTSH $5.89
  • Resistance Level
  • STRO $0.87
  • TTSH $7.00
  • Average True Range (ATR)
  • STRO 0.07
  • TTSH 0.28
  • MACD
  • STRO -0.01
  • TTSH 0.03
  • Stochastic Oscillator
  • STRO 0.00
  • TTSH 42.34

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: